These 5 stocks could move before Wall Street catches on (From TradingTips)
In Brief
- PepsiCo is positioned to deliver long-term value as it trends back toward the high end of its historical P/E range, with analysts highlighting upside potential.
- AbbVie has moved beyond Humira and is positioned for sustained growth and dividend payments, with analysts maintaining a bullish outlook.
- United Parcel Service appears to have bottomed and is working through a reversal, offering a 6.5% yield in December as analysts limit downside and see upside ahead.
A single analyst's rating and price target, the consensus rating and price target, for that matter, have little value to investors without the proper context. The context is the sentiment strength and trend, which for stocks like PepsiCo (NASDAQ: PEP), AbbVie (NYSE: ABBV), and United Parcel Service (NYSE: UPS), is strong and bullish.
The sentiment strength is reflected in the number of analysts covering and the level of recent activity; the trend is the direction of revisions, either higher or lower, and in whether they are leading the market with an increasing or declining consensus price target. This article examines the sentiment trends for the aforementioned stocks and their (bullish) implications for investors in 2026.
Everyone's buying Nvidia. The financial media can't stop talking about it. Your neighbor probably owns it.
That's exactly why I'm looking elsewhere.
See, when everyone piles into the same trade, the easy money is already gone. The real profits come from finding what the crowd is missing.
Click here to get your free copy of this report
PepsiCo Analysts Highlight a Deep-Value/High-Yield Opportunity
PepsiCo, like other consumer staples stocks, has struggled in recent years. The impacts of recalls, compounded by macroeconomic headwinds and consumer shifts, resulted in tepid growth and lackluster stock performance, but those days are behind it. The market has priced in the worst; improvements are taking hold, and analysts' sentiment trends shifted back into an accumulative posture late in 2025.
MarketBeat tracks 15 Q4 revisions as of mid-December, including numerous price target increases and several upgrades. The consensus rating is a Hold, but the bias is bullish, with coverage up year-over-year, upgrades in the mix, and eight of the 22 total ratings pegged at Buy. The consensus price target, up from its mid-year low, forecasts a 5% upside from the critical resistance point. Regarding the value, PepsiCo’s P/E has run closer to 25x earnings on average, suggesting a significantly larger upside is possible. Long-term forecasts put PEP stock at approximately 15x its 2030 earnings, implying as much as 50% upside.
The analysts' shift highlights the value and yield opportunities, with PepsiCo trading near the low end of its historic P/E range and the dividend yield at 3.75%, near the high end of its range. Technically, the stock price retreated to a long-term uptrend line in 2025, triggering a trend-following signal indicating steadily increasing price action in 2026.
AbbVie Uptrend Is Healthy and Intact
AbbVie’s analysts' activity reveals that its Q4 price pullback is setting up a buying opportunity. MarketBeat tracked more than a dozen revisions from among 25 analysts, including a few downgrades, but the upgrades and price target increases offset them, keeping the uptrend intact. The two downgrades are to Hold and are accompanied by consensus-affirming price targets; the remainder of the activity is reaffirmed bullish ratings and price targets, price target increases, and two upgrades to Buy.
The takeaway is that ABBV’s coverage is strong and steady, and sentiment is firm, with a rising price target, despite some mixed sentiment. Consensus forecasts a 10% upside, sufficient for a fresh all-time high, and the business trend suggests it will continue to move higher.
AbbVie’s driving factor is its move away from Humira. Once dependent on it for revenue, AbbVie now has a solid portfolio of fresh blockbusters, a well-diversified product portfolio, and a healthy pipeline to ensure future results. The dividend yields an annualized 3.08% in December and is of Dividend King quality due to its healthy balance sheet and history with Abbott Laboratories.
While President Trump's official salary is $400,000 per year... his tax returns reveal he's been collecting up to $250,000 PER MONTH from one hidden source. Until recently, most Americans couldn't touch the type of investment that makes up this investment. But thanks to Executive Order 14330, that just changed. If you love investing in disruptive new companies...
Discover how to invest in the fund Trump uses to collect this income >>
United Parcel Service: High Yield With Limited Downside
United Parcel Service stock is not without risks, but analysts' sentiment trends limit the downside. MarketBeat data reveals eight revisions from 30 analysts following its Q3 release, providing ample coverage and reasonable conviction in the sentiment shift.
All affirm the consensus target, forecasting a 10% upside from critical support, with six price targets increased and one upgrade. The consensus is Hold, but the bias is now bullish, and the price target trend is leading to an above-consensus price point. A move to $110 is sufficient to trigger a technical reversal in this market.
The price action is favorable for this 6.5% yielding stock. The market hit a bottom in Q4 and rebounded, regaining support at the cluster of moving averages. This is a critical level that reveals buying among near-term and short-term traders and long-term investors, suggesting that market forces are synchronizing. In this scenario, UPS stock could confirm its reversal within weeks and then continue higher in 2026.
Read this article online ›
0 Response to "3 Dividend Growth Stocks Analysts Are Upgrading for 2026"
Post a Comment